Volume 4, Issue 2, June 2020, Page: 47-51
The Use of a Modified Blood Pressure Device to Detect Atrial Fibrillation in Outpatients
Haroldas Razvadauskas, Department of Internal Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania
Laima Jankauskienė, Department of Cardiology, Kaunas Clinical Hospital, Kaunas, Lithuania
Albinas Naudžiūnas, Department of Internal Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania
Received: Mar. 6, 2020;       Accepted: Mar. 24, 2020;       Published: Apr. 21, 2020
DOI: 10.11648/j.ccr.20200402.13      View  69      Downloads  26
Abstract
The prevalence and integration of self-monitoring devices is increasing across healthcare systems, [1] and this is leading to patients taking greater responsibility for their health and well-being. Our aim was to compare two groups of patients with reoccurring atrial fibrillation (AF) and their ability to detect AF with the Microlife BP A6 device. The groups were divided according to being symptomatic or asymptomatic for AF. Method: The study was conducted for 3 years. The patients were selected from Kaunas clinical hospital in Kaunas, Lithuania. In total, 60 people took part in the study. The major criterion for inclusion was based on patients having AF upon arrival. During the period of hospitalisation, they were restored to having sinusoidal rhythm (SR). There were two groups of patients in the study. The first group had clear symptoms during the onset of rhythm disturbance and the second group was asymptomatic. All patients under the age of 18 years and those who did not sign the agreement to participate were excluded from the study. The patients were contacted every 6 months by phone call and a questionnaire was filled. The statistical analysis was performed using SPSS 23 and Microsoft Office Excel 2007 software. The results were deemed statistically significant when p<0.05. Results: There is a statistical difference between the symptomatic and asymptomatic AF patients as compared to how useful they found the device and its effect on anxiety (p<0.05). There was no statistical difference between the two groups on how frequently they used the device. The research also shows that there was no difference based on gender, education levels. Conclusion: There is a statistically significant portion of AF asymptomatic patients that find the Microlife BP A6 “very useful” and an anxiety reliever as compared to patients that are symptomatic for the condition. Both groups have statistically equally poor adherence in using the device at home.
Keywords
Atrial Fibrillation, AF, Secondary Prevention of Atrial Fibrillation, Stroke, Self-monitoring Device, Microlife BP A6
To cite this article
Haroldas Razvadauskas, Laima Jankauskienė, Albinas Naudžiūnas, The Use of a Modified Blood Pressure Device to Detect Atrial Fibrillation in Outpatients, Cardiology and Cardiovascular Research. Vol. 4, No. 2, 2020, pp. 47-51. doi: 10.11648/j.ccr.20200402.13
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Sanders JP, Loveday A, Pearson N, Edwardson C, Yates T, Biddle SJ, Esliger DW. Devices for Self-Monitoring Sedentary Time or Physical Activity: A Scoping Review. J Med Internet Res 2016; 18 (5): e90.
[2]
Cappuccio Francesco P, Kerry Sally M, Forbes Lindsay, Donald Anna. Blood pressure control by home monitoring: meta-analysis of randomised trials BMJ 2004; 329: 145.
[3]
Antonio Di Carlo, Leonardo Bellino, Domenico Consoli, Fabio Mori, Augusto Zaninelli, Marzia Baldereschi, Alessandro Cattarinussi, Maria Grazia D’Alfonso, Chiara Gradia, Bruno Sgherzi, Giovanni Pracucci, Benedetta Piccardi, Biancamaria Polizzi, Domenico Inzitari, National Research Program: Progetto FAI. La Fibrillazione Atriale in Italia, Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI Project, EP Europace, Volume 21, Issue 10, October 2019, Pages 1468–1475.
[4]
Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei, Manuel Castella, Hans-Christoph Diener, Hein Heidbuchel, Jeroen Hendriks, Gerhard Hindricks, Antonis S Manolis, Jonas Oldgren, Bogdan Alexandru Popescu, Ulrich Schotten, Bart Van Putte, Panagiotis Vardas, ESC Scientific Document Group, 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, European Heart Journal, Volume 37, Issue 38, 7 October 2016, Pages 2893–2962.
[5]
Vrijens B, Antoniou S, Burnier M, de la Sierra A, Volpe M. Current Situation of Medication Adherence in Hypertension. Front Pharmacol. 2017; 8: 100. Published 2017 Mar 1.
[6]
Joseph Wiesel, Lorenzo Fitzig, Yehuda Herschman, Frank C. Messineo, Detection of Atrial Fibrillation Using a Modified Microlife Blood Pressure Monitor, American Journal of Hypertension, Volume 22, Issue 8, August 2009, Pages 848–852.
[7]
Prati, L.; Pecchioli, V.; Germano’, G.; Fedele, F. BP A6 PC (Microlife) vs help check (picolution) for atrial fibrillation screenin in the hypertension population. A comparative study between two automatic oscilloetric devices. Journal of Hypertension: June 2015 - Volume 33 - Issue - p e152.
[8]
Lip GYH, Freedman B, De Caterina R, Potpara TS. Stroke prevention in atrial fibrillation: past, present and future. Thromb Haemost 2017; 117: 1230-9.
[9]
Hisashi Ogawa, Yoshimori An, Syuhei Ikeda, Yuya Aono, Kosuke Doi, Mitsuru Ishii, Moritake Iguchi, Nobutoyo Masunaga, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Gregory Y. H. Lip, Masaharu Akao. Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events. Stroke. 2018; 49: 2301–2308.
[10]
Polychronis E. Dilaveris and Harold L. Kennedy. Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact. Clin Cardiol. 2017 Jun; 40 (6): 413-418.
[11]
Michel Burnier, Brent M. Egan. Adherence in Hypertension. Circulation Research. 2019; 124: 1124–1140.
[12]
Marston HR, Hadley R, Banks D, Duro MDCM. Mobile Self-Monitoring ECG Devices to Diagnose Arrhythmia that Coincide with Palpitations: A Scoping Review. Healthcare (Basel). 2019; 7 (3): 96. Published 2019 Aug 16.
[13]
Nicole Lowres, Georgina Mulcahy, Robyn Gallagher, Saul Ben Freedman, David Marshman, Ann Kirkness, Jessica Orchard, Lis Neubeck, Self-monitoring for atrial fibrillation recurrence in the discharge period post-cardiac surgery using an iPhone electrocardiogram, European Journal of Cardio-Thoracic Surgery, Volume 50, Issue 1, July 2016, Pages 44–51.
[14]
Severino P, Mariani MV, Maraone A, et al. Triggers for Atrial Fibrillation: The Role of Anxiety. Cardiol Res Pract. 2019: 1208505. Published 2019 Feb 18. doi: 10.1155/2019/1208505.
[15]
Harada CN, Natelson Love MC, Triebel KL. Normal cognitive aging. Clin Geriatr Med. 2013; 29 (4): 737–752. doi: 10.1016/j.cger.2013.07.002.
Browse journals by subject